Dr. Max Kates, MD

Claim this profile

John Hopkins University

Studies Bladder Cancer
Studies Transitional Cell Carcinoma
2 reported clinical trials
3 drugs studied

Area of expertise

1

Bladder Cancer

Max Kates, MD has run 2 trials for Bladder Cancer. Some of their research focus areas include:

Stage II
Stage I
2

Transitional Cell Carcinoma

Max Kates, MD has run 1 trial for Transitional Cell Carcinoma. Some of their research focus areas include:

Stage II
Stage I

Affiliated Hospitals

Image of trial facility.

John Hopkins University

More about Max Kates, MD

Clinical Trial Related

5 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical Trials

Treatments Max Kates, MD has experience with

  • Docetaxel
  • Gemcitabine
  • UGN-102

Breakdown of trials Max Kates, MD has run

Transitional Cell Carcinoma

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Max Kates, MD specialize in?

Is Max Kates, MD currently recruiting for clinical trials?

Are there any treatments that Max Kates, MD has studied deeply?

What is the best way to schedule an appointment with Max Kates, MD?

What is the office address of Max Kates, MD?

Is there any support for travel costs?